Skip to main content
. 2009 Mar;2(1):8–16. doi: 10.1111/j.1753-5174.2009.00017.x

Table 3.

Adverse events reported in >10% of participants

Arm 1 Arm 2
Body system/Adverse event

Total participants with at least one adverse event Saquinavir/Ritonavir (N = 14) Saquinavir/Ritonavir + Rifampin (N = 8) Rifampin (N = 14) Rifampin + Saquinavir/Ritonavir (N = 9)
Transaminase elevation 2 9
Hepatomegaly 2 5
Chromaturia 9
Gastrointestinal disorder
Nausea 4 1 8
Abdominal pain 2 1 1 4
Vomiting 4
Flatulence 1 1 2
Nervous system disorders
Headache 2